Bilajoy-M Tablet

Introduction

Bilajoy-M is a prescription medication that contains two active ingredients: Bilastine and Montelukast. Bilastine is an antihistamine, while Montelukast is a leukotriene receptor antagonist. This combination medication is primarily used to treat symptoms associated with allergic rhinitis and asthma.

Uses

Bilajoy-M is prescribed to manage the symptoms of allergic rhinitis, such as sneezing, itching, runny nose, and nasal congestion. It is also effective in relieving symptoms of asthma, including wheezing, coughing, and shortness of breath.

Dosage and Administration

The recommended dosage of Bilajoy-M may vary depending on the severity of symptoms and the patient’s individual response to treatment. Follow the instructions provided by your healthcare professional. Generally, the usual adult dose is one tablet taken orally once daily, preferably in the evening.

Mechanism of Action

Bilastine, one of the active ingredients in Bilajoy-M, works by blocking the histamine H1 receptors in the body. This helps to reduce the allergic response and alleviate symptoms such as itching, sneezing, and runny nose. Montelukast, the other active ingredient, works by blocking the action of leukotrienes, substances in the body that cause inflammation and narrowing of the airways in asthma.

Side Effects

Common side effects may include drowsiness, headache, dizziness, and dry mouth. If any of these side effects persist or worsen, consult your healthcare professional.

Serious side effects are rare, but they can occur. If you experience symptoms such as difficulty breathing, chest tightness, or swelling of the face, lips, tongue, or throat, seek immediate medical attention.

Drug Interactions

Bilajoy-M may interact with certain medications, so inform your healthcare professional about all the medications you are taking, including over-the-counter drugs, vitamins, and herbal supplements. Some medications that may interact with Bilajoy-M include ketoconazole, erythromycin, and rifampin. These interactions can affect the effectiveness or increase the risk of side effects of Bilajoy-M.

Precautions

Before taking Bilajoy-M, inform your healthcare professional about any medical conditions you may have, especially liver or kidney problems. Bilajoy-M should be used with caution in patients with impaired liver or kidney function.

Note that Bilajoy-M is not recommended for use in children under the age of 12.

Storage

Bilajoy-M should be stored at room temperature, away from moisture and heat. Keep the medication out of the reach of children and pets.

Patient Tips

• Take Bilajoy-M exactly as prescribed by your healthcare professional. Do not exceed the recommended dose or take it for longer than prescribed.
• If you forget to take a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Avoid consuming alcohol while taking Bilajoy-M, as it may increase the risk of drowsiness or dizziness.
• If you are pregnant, planning to become pregnant, or breastfeeding, consult your healthcare professional before taking Bilajoy-M.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Montelukast: a medicine to prevent asthma symptoms (NHS UK) [Accessed 10 Jun. 2024] (online) Available at:
• Ilaxten 10 mg orodispersible tablets (Health Professionals SmPC) Available at:
• Bilastine (International database) (Drugs.com) [Accessed 21 Jun. 2024] (online) Available at:
• montelukast (singulair) (RX) [Accessed 25 Jun. 2024] (online) Available at:
• Montelukast (MedlinePlus) [Accessed 22 Jun. 2024] (online) Available at:
• Singh Randhawa A, Mohd Noor N, Md Daud MK, Abdullah B. Efficacy and Safety of Bilastine in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis. Front Pharmacol. 2022 Jan 10;12:731201. doi: 10.3389/fphar.2021.731201. eCollection 2021. [Accessed 6 Jun. 2024] Available at: